Hooftman Leon 4
4 · Barinthus Biotherapeutics plc. · Filed Jun 18, 2024
Insider Transaction Report
Form 4
Hooftman Leon
Chief Medical Officer
Transactions
- Award
Share Option (Right to Buy)
2024-06-03+195,166→ 195,166 totalExercise: $2.00Exp: 2034-06-03→ Ordinary Shares (195,166 underlying)
Footnotes (2)
- [F1]The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on June 3, 2025.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.